bendroflumethiazide has been researched along with Diabetic Glomerulosclerosis in 5 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Captopril is a valuable new drug for treating hypertension in insulin dependent diabetics with nephropathy." | 6.66 | Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. ( Hommel, E; Parving, HH; Smidt, UM, 1988) |
| "Treatment of patients with type 2 diabetes with Irbesartan decreased urinary excretion of MG-H1, G-H1 and 3-NT, which may result from decreased exposure to these AGEs." | 2.77 | Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria. ( Adaikalakoteswari, A; Parving, HH; Rabbani, N; Rossing, K; Rossing, P; Tarnow, L; Thornalley, PJ, 2012) |
| "Captopril is a valuable new drug for treating hypertension in insulin dependent diabetics with nephropathy." | 2.66 | Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. ( Hommel, E; Parving, HH; Smidt, UM, 1988) |
| "Eighteen hypertensive IDDM patients with diabetic nephropathy, who had not been treated previously, were followed during 3 years of treatment with captopril and frusemide or bendrofluazide." | 1.29 | Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. ( Hommel, E; Parving, HH; Rossing, P; Smidt, UM, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rabbani, N | 1 |
| Adaikalakoteswari, A | 1 |
| Rossing, K | 1 |
| Rossing, P | 3 |
| Tarnow, L | 1 |
| Parving, HH | 5 |
| Thornalley, PJ | 1 |
| Hommel, E | 4 |
| Smidt, UM | 3 |
| Larsen, M | 1 |
| Lund-Andersen, H | 1 |
3 trials available for bendroflumethiazide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria.
Topics: Albuminuria; Amino Acids; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bendrofl | 2012 |
Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Bendroflumethiazide; Blood Pressure; C | 1995 |
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Typ | 1988 |
2 other studies available for bendroflumethiazide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
Topics: Adult; Albuminuria; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Captopril; Diabete | 1994 |
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Capto | 1989 |